Day: March 17, 2019

Interim Analysis Showed Treatment with OPSUMIT® (macitentan) Associated with Significant Improvement in Right Ventricular (RV) Function and Pulmonary Vascular Resistance (PVR) in Patients with Pulmonary Arterial Hypertension (PAH)

Shimadzu Corporation Releases Nexera Ultra High-Performance Liquid Chromatograph Series, Incorporating Artificial intelligence as Analytical Intelligence, to Detect and Resolve Issues Automatically

error: Content is protected !!